Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Shares Drop on Profit Taking

NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences dropped 8.3 percent on Thursday, giving back some of its gains from the previous week.
As reported by GenomeWeb Daily News on Wednesday, Helicos shares had risen 76 percent from $10.50 on Jan. 8 to a high of $18.50 on Wednesday before closing at $17.44.
On Thursday, investors took profits, and the firm’s shares closed at $16. At one point during the day, Helicos’ stock had fallen all the way to $13.60.
Trading volume for the firm’s shares was up roughly 11 percent over its daily average.
The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.